In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Hold rating on Caribou Biosciences (CRBU – Research Report), with a ...

In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Factset Research (FDS – Research Report), with a ...

Carvana (NYSE:CVNA – Free Report) had its price target lowered by Evercore ISI from $250.00 to $240.00 in a report issued on ...

Capital One Financial Corp (COF) shares attracted investor attention Wednesday morning after Evercore ISI upgraded the stock ...

Evercore ISI upgraded Capital One Financial to Outperform from In Line, bolstered by the conviction that the bank's ...

Capital One Financial (NYSE:COF) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an ...

Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

Evercore ISI upgraded Capital One Financial Corp (NYSE:COF) to "Outperform" from "In Line," focusing on long-term earnings upside from its pending acquisition of Discover Financial Services (NYSE:DFS) ...

Stocks remained on track for their worst week since September, but were headed for a higher close in Friday's session, after ...

Investing.com -- The Trade Desk (NASDAQ:TTD) has lost its "premium edge", according to Evercore ISI, which downgraded the stock from Outperform to In Line following disappointing fourth-quarter ...

Evercore ISI analyst Chris McNally has lowered EV giant Tesla’s price target from $270 to $235, citing ongoing market concerns and company-specific challenges. The price downgra ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares clos ...